HK Stock Market Move | EDGE MEDICAL-B(02675) rose over 5% in the afternoon. The Edge multiport endoscopic surgical Siasun Robot&Automation has been successfully put into clinical use at FPH in Singapore.

EDGE MEDICAL-B(02675) rose over 5% in the afternoon, up 4.79% as of press time, at HK$36.44, with a turnover of HK$4.1358 million. On the news front, according to Edge Medical's official WeChat account, recently, Edge Medical welcomed a major milestone breakthrough in its global commercialization process its self-developed Edge multiport endoscopic surgical Siasun Robot&Automation completed commercial installation at Farrer Park Hospital (FPH) in Singapore and has been successfully put into clinical use. This is not only the first endoscopic Siasun Robot&Automation introduced by the hospital, but also the first Chinese-brand endoscopic Siasun Robot&Automation introduced into Singapore's healthcare system, breaking the competitive landscape of Singapore's surgical Siasun Robot&Automation market in one stroke and becoming a landmark node for Chinese surgical Siasun Robot&Automation entering the Asia-Pacific high-end medical market. It is worth mentioning that the landing of Edge's Siasun Robot&Automation at FPH and the successful completion of its first surgery made it the first Chinese-brand endoscopic surgical Siasun Robot&Automation to achieve commercial installation in Singapore. As of now, Edge's multiport endoscopic surgical Siasun Robot&Automation has obtained market access in more than 60 countries and regions worldwide, with overseas installations covering multiple regions including Europe, Asia-Pacific, the Middle East, Africa, and South America.